The glycan domain of thrombopoietin (TPO) acts in trans to enhance secretion of the hormone and other cytokines.
Thrombopoietin (TPO), the primary regulator of platelet production, is composed of an amino-terminal 152 amino acids, sufficient for activity, and a carboxyl-terminal region rich in carbohydrates (183 residues) that enhances secretion of the molecule. Full-length TPO is secreted at levels 10-20-fold greater than truncated TPO. By introducing into mammalian cells a novel cDNA encoding the TPO secretory leader linked to its carboxyl-terminal domain (TPO glycan domain (TGD)), we tested whether TGD could function in trans to enhance secretion of TPO. The artificial TGD was secreted, inactive in proliferation assays, and did not inhibit TPO activity. However, when co-transfected with a cDNA encoding truncated TPO, TGD enhanced secretion 4-fold, measured by specific bioassay and immunoassay. TGD also enhanced secretion of granulocyte monocyte colony-stimulating factor and stem cell factor but did not affect the production of erythropoietin, interleukin-3, growth hormone, or of full-length TPO. To localize TGD function, we added an endoplasmic reticulum (ER) retention signal to TGD and, separately, deleted the secretory leader. Deletion of the secretory leader attenuated the secretory function of TGD, whereas addition of the ER retention signal did not alter its function. To investigate the physiologic role of TGD in folding and proteasomal protection, we tested full-length and truncated TPO in assays of protein refolding, and we examined protein stability in the presence of proteasome inhibitors. We found that truncated TGD re-folds readily and that proteasome-mediated degradation contributes to the poor secretion of truncated TPO. We conclude that TGD enhances secretion of TPO and can additionally function as an inter-molecular chaperone, in part because of its ability to prevent degradation of the hormone. The cellular location of TGD action is likely to be within the ER or earlier in the secretory pathway.
Linden
Hannah M
HM
Division of Hematology, University of Washington School of Medicine, Seattle, Washington 98195, USA.
Kaushansky
Kenneth
K
D000595:Amino Acid Sequence; D000818:Animals; D002460:Cell Line; D003546:Cysteine Endopeptidases; D016207:Cytokines / Q000378:metabolism*; D051379:Mice; D008969:Molecular Sequence Data; D009097:Multienzyme Complexes / Q000037:antagonists & inhibitors; D016297:Mutagenesis, Site-Directed; D016133:Polymerase Chain Reaction; D011134:Polysaccharides / Q000502:physiology*; D046988:Proteasome Endopeptidase Complex; D014176:Protein Biosynthesis; D013926:Thrombopoietin / Q000737:chemistry / Q000378:metabolism / Q000502:physiology*; D014162:Transfection
D016207:Cytokines; D009097:Multienzyme Complexes; D011134:Polysaccharides; D013926:Thrombopoietin; D003546:Cysteine Endopeptidases; D046988:Proteasome Endopeptidase Complex